Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Monopar Therapeutics | Chief Financial Officer | Common Stock | 1.55K | $10.4K | $6.74 | Oct 28, 2024 | Direct |
Monopar Therapeutics | Chief Financial Officer | Stock Options | 125K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | Oct 28, 2024 | 1 | $25.2K | 4 | Oct 30, 2024 | Chief Financial Officer |
MNPR | Monopar Therapeutics | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Chief Financial Officer |
MNPR | Monopar Therapeutics | Jul 1, 2024 | 0 | $0 | 3 | Jul 3, 2024 | Chief Financial Officer |